These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 32607627)

  • 1. Thrombolysis beyond 4.5 h in Acute Ischemic Stroke.
    Etherton MR; Gadhia RR; Schwamm LH
    Curr Neurol Neurosci Rep; 2020 Jun; 20(8):35. PubMed ID: 32607627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute imaging for evidence-based treatment of ischemic stroke.
    Thomalla G; Gerloff C
    Curr Opin Neurol; 2019 Aug; 32(4):521-529. PubMed ID: 31116116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.
    Campbell BCV; Ma H; Ringleb PA; Parsons MW; Churilov L; Bendszus M; Levi CR; Hsu C; Kleinig TJ; Fatar M; Leys D; Molina C; Wijeratne T; Curtze S; Dewey HM; Barber PA; Butcher KS; De Silva DA; Bladin CF; Yassi N; Pfaff JAR; Sharma G; Bivard A; Desmond PM; Schwab S; Schellinger PD; Yan B; Mitchell PJ; Serena J; Toni D; Thijs V; Hacke W; Davis SM; Donnan GA;
    Lancet; 2019 Jul; 394(10193):139-147. PubMed ID: 31128925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.
    Thomalla G; Simonsen CZ; Boutitie F; Andersen G; Berthezene Y; Cheng B; Cheripelli B; Cho TH; Fazekas F; Fiehler J; Ford I; Galinovic I; Gellissen S; Golsari A; Gregori J; Günther M; Guibernau J; Häusler KG; Hennerici M; Kemmling A; Marstrand J; Modrau B; Neeb L; Perez de la Ossa N; Puig J; Ringleb P; Roy P; Scheel E; Schonewille W; Serena J; Sunaert S; Villringer K; Wouters A; Thijs V; Ebinger M; Endres M; Fiebach JB; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Gerloff C;
    N Engl J Med; 2018 Aug; 379(7):611-622. PubMed ID: 29766770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection.
    Ringleb P; Bendszus M; Bluhmki E; Donnan G; Eschenfelder C; Fatar M; Kessler C; Molina C; Leys D; Muddegowda G; Poli S; Schellinger P; Schwab S; Serena J; Toni D; Wahlgren N; Hacke W;
    Int J Stroke; 2019 Jul; 14(5):483-490. PubMed ID: 30947642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Treatment of Ischemic Stroke.
    Lyden S; Wold J
    Neurol Clin; 2022 Feb; 40(1):17-32. PubMed ID: 34798968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Mismatch Concepts for Magnetic Resonance Imaging-Guided Thrombolysis in Unknown Onset Stroke.
    Scheldeman L; Wouters A; Boutitie F; Dupont P; Christensen S; Cheng B; Ebinger M; Endres M; Fiebach JB; Gerloff C; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Thijs V; Thomalla G; Lemmens R;
    Ann Neurol; 2020 Jun; 87(6):931-938. PubMed ID: 32227638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute ischemic stroke: improving access to intravenous tissue plasminogen activator.
    Turner AC; Schwamm LH; Etherton MR
    Expert Rev Cardiovasc Ther; 2020 May; 18(5):277-287. PubMed ID: 32323590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).
    Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C;
    Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to Wake-Up: Extending the Window for Management of Unknown-Onset Strokes.
    Fawaz AM; Wu S; Viswanathan D; Kaur K; Nuoman R; Nuoaman H; Adnan YA; Gandhi CD; Kurian C; Sahni R
    Cardiol Rev; 2021; 29(1):26-32. PubMed ID: 32769626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data.
    Thomalla G; Boutitie F; Ma H; Koga M; Ringleb P; Schwamm LH; Wu O; Bendszus M; Bladin CF; Campbell BCV; Cheng B; Churilov L; Ebinger M; Endres M; Fiebach JB; Fukuda-Doi M; Inoue M; Kleinig TJ; Latour LL; Lemmens R; Levi CR; Leys D; Miwa K; Molina CA; Muir KW; Nighoghossian N; Parsons MW; Pedraza S; Schellinger PD; Schwab S; Simonsen CZ; Song SS; Thijs V; Toni D; Hsu CY; Wahlgren N; Yamamoto H; Yassi N; Yoshimura S; Warach S; Hacke W; Toyoda K; Donnan GA; Davis SM; Gerloff C;
    Lancet; 2020 Nov; 396(10262):1574-1584. PubMed ID: 33176180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In imaging-selected ischemic stroke with unknown onset, alteplase increases favorable outcomes and death at 90 d.
    Hill MD
    Ann Intern Med; 2021 Apr; 174(4):JC42. PubMed ID: 33819060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the management of acute ischemic stroke.
    Nair R; Wagner AN; Buck BH
    Curr Opin Neurol; 2023 Apr; 36(2):147-154. PubMed ID: 36762632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C; Bai Q; Zhao Z; Zhang J
    Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase III, prospective, double-blind, randomized, placebo-controlled trial of thrombolysis in imaging-eligible, late-window patients to assess the efficacy and safety of tenecteplase (TIMELESS): Rationale and design.
    Albers GW; Campbell BC; Lansberg MG; Broderick J; Butcher K; Froehler MT; Schwamm LH; Nouh AM; Liebeskind DS; Toy F; Yang M; Massaro L; Schoeffler M; Purdon B
    Int J Stroke; 2023 Feb; 18(2):237-241. PubMed ID: 35262424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous thrombolysis in unwitnessed stroke onset: MR WITNESS trial results.
    Schwamm LH; Wu O; Song SS; Latour LL; Ford AL; Hsia AW; Muzikansky A; Betensky RA; Yoo AJ; Lev MH; Boulouis G; Lauer A; Cougo P; Copen WA; Harris GJ; Warach S;
    Ann Neurol; 2018 May; 83(5):980-993. PubMed ID: 29689135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Perfusion Imaging for Intravenous Thrombolysis Treatment.
    Slawski Md DE; Albers Md GW
    Top Magn Reson Imaging; 2021 Aug; 30(4):205-209. PubMed ID: 34397970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.